Taurbekova Binura, Tursunov Abay, Kabibulatova Aida, Muxunov Alimzhan, Issabayeva Assel, Atageldiyeva Kuralay, Sydykova Kamilya, Durmanova Aigul, Markabayeva Akbayan, Starodubov Andrey, Mukhtarova Kymbat, Almawi Wassim Y, Sarria-Santamera Antonio
Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana, Kazakhstan.
Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.
Front Med (Lausanne). 2025 Jul 10;12:1630725. doi: 10.3389/fmed.2025.1630725. eCollection 2025.
Diabetic kidney disease (DKD) is a common microvascular complication of type 2 diabetes mellitus (T2DM). Given vitamin D's roles in glucose metabolism and renal function, this study investigated associations between common variants in vitamin D pathway genes (, , ) and DKD risk.
This case-control study included 170 patients with DKD, 157 patients without DKD, and 118 normoglycemic healthy controls. Four single nucleotide polymorphisms (SNPs) in the (rs17470271), (rs1074165), and (rs4588 and rs7041) were genotyped using real-time PCR with defined clusters.
The rs17470271 T/T genotype was significantly associated with a reduced risk of DKD under the recessive model (AOR = 0.32, 95% CI: 0.11-0.93). A similar protective association for rs17470271 T/T genotype was observed under the codominant model (OR = 0.34, 95% CI: 0.12-0.99), although this did not remain statistically significant after adjustment. Likewise, the rs4588 T/T genotype was strongly associated with a decreased risk of DKD under the recessive (AOR = 0.30, 95% CI: 0.10-0.88) and codominant (AOR = 0.28, 95% CI: 0.09-0.85) models. However, haplotype analysis revealed contrasting findings, with the haplotype carrying the rs4588 G and rs7041 C alleles being associated with an increased risk of DKD compared with healthy controls.
These findings suggest that individual variants in vitamin D pathway genes may serve as potential genetic markers for DKD risk stratification. In addition, haplotype analysis may offer complementary insight into genetic contributions to disease susceptibility.
糖尿病肾病(DKD)是2型糖尿病(T2DM)常见的微血管并发症。鉴于维生素D在葡萄糖代谢和肾功能中的作用,本研究调查了维生素D途径基因(、、)中的常见变异与DKD风险之间的关联。
这项病例对照研究纳入了170例DKD患者、157例非DKD患者和118例血糖正常的健康对照。使用带有特定簇的实时PCR对基因(rs17470271)、基因(rs1074165)和基因(rs4588和rs7041)中的四个单核苷酸多态性(SNP)进行基因分型。
在隐性模型下,基因rs17470271的T/T基因型与DKD风险降低显著相关(优势比[AOR] = 0.32,95%置信区间[CI]:0.11 - 0.93)。在共显性模型下观察到基因rs17470271的T/T基因型有类似的保护关联(OR = 0.34,95% CI:0.12 - 0.99),尽管调整后这在统计学上不再显著。同样,在隐性(AOR = 0.30,95% CI:0.10 - 0.88)和共显性(AOR = 0.28,95% CI:0.09 - 0.85)模型下,基因rs4588的T/T基因型与DKD风险降低密切相关。然而,单倍型分析得出了相反的结果,与健康对照相比,携带rs4588 G和rs7041 C等位基因的单倍型与DKD风险增加相关。
这些发现表明,维生素D途径基因中的个体变异可能作为DKD风险分层的潜在遗传标记。此外,单倍型分析可能为疾病易感性的遗传贡献提供补充见解。